Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-TYRP1, 20D7S Vector   (CAT#: GTVCR-WQ73MR)

This product GTVCR-WQ73MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting TYRP1. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Homo sapiens
RefSeq NM_000550.3
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 7306
UniProt ID P17643
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-TYRP1, 20D7S Vector (GTVCR-WQ73MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1671MR IVTScrip™ pT7-VEE-mRNA-Anti-env, KD-247 Vector Vector KD-247
GTVCR-WQ489MR IVTScrip™ pSP6-VEE-mRNA-Anti-CCR4, AMG-761 Vector Vector AMG-761
GTVCR-WQ823MR IVTScrip™ pT7-VEE-mRNA-Anti-ACVR2, BYM338 Vector Vector BYM338
GTVCR-WQ1750MR IVTScrip™ pSP6-VEE-mRNA-Anti-MSTN, LY-2495655 Vector Vector LY-2495655
GTVCR-WQ1512MR IVTScrip™ pT7-VEE-mRNA-Anti-MST1R, IMC RON-8 Vector Vector IMC RON-8
GTVCR-WQ2093MR IVTScrip™ pSP6-VEE-mRNA-Anti-MUC5AC, NOE-102 Vector Vector NOE-102
GTVCR-WQ1295MR IVTScrip™ pT7-VEE-mRNA-Anti-GLP1R, GLP-1Fc Vector Vector GLP-1Fc
GTVCR-WQ1031MR IVTScrip™ pT7-VEE-mRNA-Anti-CTLA4, CP-675 Vector Vector CP-675
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW